Search results
Results from the WOW.Com Content Network
An estimated 31.1 percent of all American adults will experience some form of anxiety disorder during their lives, and many of those people could benefit from one of the many tested, proven ...
Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure and heart failure. [3] [6] It is a reasonable initial treatment for high blood pressure. [6] It is taken by mouth. [6] Common side effects include upper respiratory tract infections, diarrhea, and back pain. [6]
Telmisartan is, on the other hand, in part metabolized by glucuronidation and olmesartan is excreted as the unchanged drug. [23] Telmisartan is the only ARB that can cross the blood–brain barrier and can therefore inhibit centrally mediated effects of Ang II, contributing to even better blood pressure control.
Angiotensin II receptor blockers are used primarily for the treatment of hypertension where the patient is intolerant of ACE inhibitor therapy primarily because of persistent and/or dry cough. [ 6 ] [ 7 ] They do not inhibit the breakdown of bradykinin or other kinins , and are thus only rarely associated with the persistent dry cough and/or ...
According to the National Institute of Mental Health, more than 31% of U.S. adults experience an anxiety disorder at some time in their lives, and about 1 in 5 had any anxiety disorder in the past ...
Benzodiazepines are not recommended for the treatment of PTSD due to a lack of evidence of benefit and risk of worsening PTSD symptoms. [139] Benzodiazepines are a group of anti-anxiety medications that make people feel calm, relaxed, or sleepy. [140] They are recommended for short-term treatment of severe anxiety, panic, or insomnia.
Follow-up treatment is still poorly studied, but about half of people who respond relapse with twelve months. [144] Aside from effects in the brain, the general physical risks of ECT are similar to those of brief general anesthesia. [145]: 259 Immediately following treatment, the most common adverse effects are confusion and memory loss.
Guanfacine has been studied as a treatment for post-traumatic stress disorder (PTSD). Evidence of efficacy in adults is limited, but one study found positive results in children with comorbid ADHD. [64] It may be also useful in adult PTSD patients who do not respond to selective serotonin reuptake inhibitors (SSRIs). [65]